Physician profile
Daniel Sciortino
NPI 1588369821
$5,688.55
in general payments reported to CMS, 2019-2025
16 companies · $1,947 in 2025
The $1,947 reported for 2025 was more than what 92% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.25 · 2023: $1,651 · 2024: $2,077 · 2025: $1,947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,567 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,566.78 |
| Education | $107.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,132.13 | 2023-2025 | |
| Alkermes, INC. | $695.40 | 2023-2025 | Aristada, Lybalvi, Aristada Initio |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $663.35 | 2021-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $637.11 | 2023-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Otsuka America Pharmaceutical, INC. | $371.30 | 2023-2025 | Abilify Asimtufii, Rexulti, Abilify Maintena |
| E.R. Squibb & Sons, L.L.C. | $355.05 | 2025 | Cobenfy |
| Lundbeck LLC | $348.35 | 2023-2025 | Abilify Maintena, Rexulti |
| Vanda Pharmaceuticals INC. | $335.59 | 2024-2025 | Fanapt |
| Neurocrine Biosciences, INC. | $301.81 | 2023-2025 | Ingrezza |
| Axsome Therapeutics, INC. | $276.28 | 2023-2025 | Auvelity |
| Corium, LLC | $193.16 | 2023-2024 | Azstarys |
| Tris Pharma INC | $122.55 | 2024 | Quillichew Er, Dyanavel Xr, Quillivant |
| Almatica Pharma LLC | $99.38 | 2024-2025 | Loreev Xr |
| Janssen Pharmaceuticals, INC | $84.38 | 2023-2025 | Invega Sustenna |
| Takeda Pharmaceuticals U.S.A., INC. | $57.34 | 2023-2025 | Trintellix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $15.37 | 2023 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sciortino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.